Pfizer (PFE) chairman and CEO Albert Bourla joins Julie Hyman on Market Domination to talk more about the pharmaceutical ...

Exclusive interview with Pfizer CEO Albert Bourla as the company files for emergency use authorization for its COVID-19 ...

The pharma company had to scale vaccine production from 200 million annually to 3 billion at the pandemic's peak.

The data on Pfizer's GLP-1 offer early evidence that the injection can be administered less frequently than existing drugs ...

A U.K. marketing watchdog has sanctioned Sanofi after ruling its CEO Paul Hudson may have undermined the U.K. government’s ...

Kathy Wylde, the head of the Partnership for New York City, lost the support of the high-powered CEOs who make up the ...

By Michael Erman and Mrinalika Roy Feb 3 (Reuters) - Pfizer on Tuesday released trial data on a high-profile obesity drug ...

The stock price of BridgeBio plunged 15% Thursday as Pfizer’s reported decision to withdraw a tafamidis patent in the European Union triggered fears of earlier generic entry in the blockbuster ...

Both products can be used in the UK to provide protection against RSV disease in certain settings. Abrysvo was cleared for ...

Feb 2 (Reuters) - Sanofi has breached the UK pharma code of practice with unsubstantiated claims that its Beyfortus was more ...

Geoff Meacham, Citi Research head of U.S. pharmaceuticals and biotechnology, joins 'Squawk Box' to break down the quarterly ...

After Mamdani won the primary, Wylde pushed to stay on beyond the end of the year; the Partnership board said no and ...